CellAxia Overview

  • Founded
  • 2017

Founded
  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $7.07M

  • Investors
  • 7

CellAxia General Information

Description

Operator of a biotechnology company intended to develop cell therapy drugs. The company is engaged in the discovery, development, and commercialization of first-in-class biological therapies for the treatment of intractable autoimmune diseases, thereby enabling researchers to use difficult to transect cells like primary and cancer stem cell cultures and discover new therapeutic cell-based therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 1-10-9 Nihonbashi Horidome-cho, Chuo-ku
  • 6th Floor, Logs Nihonbashi Horidome Building
  • Tokyo, Chuo-ku 103-0012
  • Japan
+81 00-0000-0000

CellAxia Timeline

2019202020212022
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellAxia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 11-Sep-2020 $7.07M 000.00 000.00 Completed Generating Revenue
1. Early Stage VC 28-Jan-2019 00.000 00.000 000.00 Completed Generating Revenue
To view CellAxia’s complete valuation and funding history, request access »

CellAxia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B Preferred 0,000 00000.00 00000.00 00 00000.00 00.000
Class A Preferred 0,000 0000.00 0000.00 00 0000.00 00.000
To view CellAxia’s complete cap table history, request access »

CellAxia Executive Team (1)

Name Title Board Seat Contact Info
Makoto Seki Founder, Chief Executive Officer & President
To view CellAxia’s complete executive team members history, request access »

CellAxia Board Members (3)

Name Representing Role Since
Hiroyuki Misawa Ph.D Miyako Capital Board Member 000 0000
Shuichiro Kadowaki CellAxia Board Member 000 0000
Tadashi Hishida CellAxia Audit & Supervisory Board Member 000 0000
To view CellAxia’s complete board members history, request access »

CellAxia Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FFG Venture Business Partners Venture Capital Minority 000 0000 000000 0
Japan Asia Investment PE/Buyout Minority 000 0000 000000 0
M3 Corporation Minority 000 0000 000000 0
MCP Partners PE/Buyout Minority 000 0000 000000 0
Mitsubishi UFJ Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »